
Mark your calendars #AictPCR #AsiaPCR @PCRonline October 10-11, 2025 New venue Singapore 🇸🇬 Submit your work Register early pcronline.com/Courses/AICT-A…

ASIAN PACIFIC SOCIETY OF INTERVENTIONAL CARDIOLOGY (APSIC): Conceptualized 26 years ago

Mark your calendars #AictPCR #AsiaPCR @PCRonline October 10-11, 2025 New venue Singapore 🇸🇬 Submit your work Register early pcronline.com/Courses/AICT-A…

Honored to step into the role of Co-Chair of the Gender & Disparities Committee of @EAPCI .Representing India on this global platform is a privilege, and I am grateful for the opportunity to work alongside our Chair, @giuliamasiero3 and Pillar Chair @HawranekMichal as well as an inspiring group of dedicated committee members from across the globe. Cardiovascular disease remains the leading cause of mortality in women, yet significant disparities persist—both in how women are diagnosed and treated in the cath lab, and in the representation of women within interventional cardiology itself. Bridging these gaps requires sustained global collaboration, data-driven advocacy, mentorship, and actionable policy change. I look forward to fostering cross-continental partnerships that elevate women's cardiovascular care and empower the next generation of female interventional cardiologists worldwide. Thank you to @alaide_chief @nickaram for the trust and support @IJCDW_WINCARS @escardio @PCRonline @WomenAs1 @C3_Academy @APSIC6 @HospitalsApollo @mmamas1973 @mirvatalasnag @DrMarthaGulati @Marta33717088

I am a believer in #YesCCT here are 2 examples..would like to see the community learn advantages & limitations of this technology Case 1 myocardial bridge (middle aged man) Case 2 SCAD (middle aged woman)
NSTEMI: how would you treat❓


🚨 A new chapter in stroke prevention: Factor XIa inhibition has officially entered clinical practice. 🧵 The FDA has approved *Asundexian (Sunharbo) 50 mg once daily, the first FDA-approved Factor XIa inhibitor, for secondary prevention after recent non-cardioembolic ischemic stroke or high-risk TIA, in combination with antiplatelet therapy. And the data are worth looking beyond the headline. @ASPCardio @ESPM_org @APSIC6 @Dr_Shiv_kumar_ #stroke #CardioX #cardiotwitter #MedTwitter

Fatigue indeed~ Here’s a case done after @TCTConference of a 79M w previous Des LM/LAD as a provisional strategy where ostium of LM was not stented per latest practices Now apparent stent deformation w severe dz progression of ostial LCX Treated w IVUS guided Culotte using a Megatron given the size discrepancy btwn LM & LCX (mid LCX stented first)..no MCS as patient was medically optimized w normal EDP PROTECT II: MCS device is obsolete & we learned that extensive PCI doesn’t improve outcomes My practice for 17 years since Michigan training is MCS when necessary only & minimalistic PCI w or w/out MCS..these high risk cases especially if they have a very low EF tend to behave similar to shock, so best approach is conservative revasc ie culprit only ~ SCAI shock class A (they can decompensate at any point)
@CHIP_BCIS3 fatigue! 😂 The disagreement is in WHAT we have learned. Haha. I don’t recall there being a decent crossover. Only one patient unless I am mistaken. @hollymorgs @AishSinha1 @divaka_perera

Our story with the tricuspid valve started a decade ago & went from off label implant of Edwards Sapien to TV-TEER, & finally dedicated Evoque implantation. Over the decade we’ve learned that imaging is integral & grateful our imagers are in fact the best 💝 Also glad we contributed to the global registry & learning from collective experiences.. recently presented @AHAScience 👉 ahajournals.org/doi/abs/10.1… @KFAFHCards @fayezbaraah @drptca @m_alfawara @JGrapsa

🔍 Does PCI complexity alter #IVI benefits? A new RENOVATE-COMPLEX-PCI analysis reveals a major shift in outcomes based on procedural risk. 👇 See which subgroups benefit most: asiaintervention.org/article… @APSIC6 @EuroInterventio @PCRonline #CardioTwitter

Deeply humbled and honored to be recognized by the American Association of Cardiologists of Indian Origin (AACIO) in CHICAGO for my contributions to Interventional cardiology and my work in advancing WOMEN in Cardiology in India. Standing among esteemed colleagues, mentors, and leaders in cardiovascular medicine on an international platform is a powerful reminder of why we do what we do. Every complex procedure, every innovation we bring to Central India, and every barrier we break in opening doors for women in this specialty is driven by a shared commitment to elevating patient care and medical education. Heartfelt thanks to AACIO for this wonderful honor and special thanks to @navinnanda1 @WomenAs1 @IJCDW_WINCARS #DrNavinNanda #Drrakeshsharma #hkchopra @PCRonline @APSIC6

#TCT2026 coverage continues! @mirvatalasnag shares insight from a session discussing how to overcome barriers to MedTech on the global scale and reveals how inclusivity is essential to improving access. For all the latest news from TCT, click here: tctmd.com/TCT2026

@mirvatalasnag discusses late breaking science from SYNCHRONIZE-CVOT at #ScientificSessions26. 🎥

@AHAScience @AHAMeetings ✅Along the lines of brain health, OPTIMAL-STROKE noted a BP target of 120mmHg significantly reduced the composite of cardiovascular death, nonfatal MI, nonfatal stroke, or hospitalization for unstable angina or heart failure. ❗️The composite renal outcome resulted in a ≥50% reduction in eGFR or progression to end-stage renal disease in the intensive treatment arm. 👉@NEJM nejm.org/doi/full/10.1056/NE…
Heart health and brain health are inseparable. Today, we’re taking a bold step to advance both. Building on decades of leadership through the American Stroke Association, the new @American_Heart Center for the Brain™ will bring together science, expertise and action to deepen our understanding of the heart-brain connection and help people protect their brain health throughout their lives. We’ve helped generations of people live longer. Now, through the new Center for the Brain™, we’ll help people preserve the memories, independence and connections that make those years meaningful. #ScientificSessions26

More science @AHAScience @AHAMeetings 1. jamanetwork.com/journals/jam… 👉@JAMANetwork 25 years after COURAGE evidence confirms no change in death/MI post PCI ❗️this was the BMS era & medical Rx changed significantly including more potent antiplatelets & LLTs 2. nejm.org/doi/full/10.1056/NE… 👉@NEJM In those with an atrioventricular block, left bundle-branch pacing resulted in a lower incidence of a composite of death, hospitalization for heart failure, or pacing-induced cardiomyopathy than right ventricular pacing 3. nejm.org/doi/full/10.1056/NE… 👉@NEJM aldosterone synthase inhibitor, Baxdrostat, not only makes primary aldosteronism disappear, it may even induce hypoaldosteronism
As I bid Chicago @AHAScience @AHAMeetings farewell, here are important takeaways: 1) Although we already knew the results of Zeus & Lpa Horizon, the nuanced discussions on residual risk & future research directions were central & refreshing 2) Hypertension remains under-treated & a consorted global effort is imperative 3) I did not expect to see a large international presence (Asia & Africa in particular) in the Windy City..a pleasant surprise…the tides have already turned 4) Finally, I saw leadership at its finest: commissioned statements, career development & women empowerment..I also witnessed loyalty to members (rewarding active members) Let’s celebrate 🎉 100 years of @AHAScience in Boston next year 2️⃣0️⃣2️⃣7️⃣ A few parting selfies: great catching up with all of you ❤️ (my gratitude to a superb group of staffers who accommodated my tight schedule) @drstaceyrosen @Dr_HaniNajm @avolgman @VietHeartPA @AnastasiaSMihai et al @mmamas1973 we missed you @manesh_patelMD @SripalBangalore I forgot to gran a selfie

As I bid Chicago @AHAScience @AHAMeetings farewell, here are important takeaways: 1) Although we already knew the results of Zeus & Lpa Horizon, the nuanced discussions on residual risk & future research directions were central & refreshing 2) Hypertension remains under-treated & a consorted global effort is imperative 3) I did not expect to see a large international presence (Asia & Africa in particular) in the Windy City..a pleasant surprise…the tides have already turned 4) Finally, I saw leadership at its finest: commissioned statements, career development & women empowerment..I also witnessed loyalty to members (rewarding active members) Let’s celebrate 🎉 100 years of @AHAScience in Boston next year 2️⃣0️⃣2️⃣7️⃣ A few parting selfies: great catching up with all of you ❤️ (my gratitude to a superb group of staffers who accommodated my tight schedule) @drstaceyrosen @Dr_HaniNajm @avolgman @VietHeartPA @AnastasiaSMihai et al @mmamas1973 we missed you @manesh_patelMD @SripalBangalore I forgot to gran a selfie

@manesh_patelMD Meet the first South Asian President of @AHAScience @American_Heart in 100 years 💫 Within minutes he took us from the formative years with medical challenges to modern times with progress delivered through science (not magic) The next hurdle is “the last mile” which is access to care
At the #RallyforMedicalResearch, American Heart Association science leaders, including @manesh_patelMD, met with policymakers to advocate for continued investment in medical research and evidence-based science that improves health outcomes and saves lives. Join us in raising awareness about the importance of protecting strong, independent science and the processes that allow research to thrive. heartpowered.org/SaveScience

🎥 Meet the Fellows. The Fellowship journey continues. In Episode 2, Nozomu Toda and Christopher Cook share their experience at the Essex Cardiothoracic Centre and how exchanging practices and perspectives can enrich clinical learning. 👉 Watch and follow the journey with PCR. #PCRCommunity #FellowshipProgrammes #JAPAC